PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 2147149
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 2147149
The global cannula market size was valued at USD 2.41 billion in 2025 and is projected to grow from USD 2.55 billion in 2026 to USD 3.93 billion by 2034, exhibiting a CAGR of 5.5% during the 2026-2034 forecast period. North America dominated the cannula market with a 42.32% share in 2025, reaching a market value of approximately USD 1.02 billion.
Cannulas are thin, flexible tubes inserted into the body for administering medications, draining fluids, providing oxygen, and supporting various medical procedures. Growing hospital admissions, surgical procedures, infusion therapy, dialysis, chemotherapy, emergency care, respiratory support, and cardiovascular procedures are driving global demand.
Cannula Market Trends
Disposable and Closed-System Cannulas Gain Momentum
Healthcare providers are increasingly adopting disposable, single-use, closed-system, and procedure-ready cannulas. These products help reduce cross-contamination, blood exposure, accidental disconnection, infection, and needlestick injuries. Growing emphasis on clinical safety and workflow efficiency is encouraging manufacturers to develop user-friendly cannula platforms, particularly for cardiopulmonary, vascular access, and respiratory applications.
Market Drivers
Rising Hospital Procedures Drive Market Growth
Increasing demand for reliable vascular access across emergency departments, oncology, intensive care, dialysis, surgery, and general hospital wards is a major market driver. Peripheral IV cannulas and central venous access devices support fluid administration, antibiotics, chemotherapy, anesthesia, blood collection, and parenteral nutrition.
Demand is also shifting toward blood-control IV catheters, antimicrobial products, closed IV systems, and ultrasound-compatible insertion technologies as healthcare providers focus on improving patient safety.
Market Restraints
Cannula-Associated Complications Restrict Adoption
Cannulation can cause phlebitis, infiltration, thrombosis, occlusion, extravasation, bloodstream infections, dislodgement, and needlestick injuries. Such complications can increase treatment costs and clinical workload. Product recalls, sterilization requirements, and the need for proper user training can further restrain market expansion.
Market Opportunities
Advanced Vascular Access Solutions Create Opportunities
An aging population and increasing prevalence of chronic diseases, cancer, renal disorders, and critical illnesses are creating opportunities for safety-engineered and extended-dwell products. Safety IV cannulas, midline catheters, PICCs, intraosseous cannulas, and blood-control IV catheters are gaining importance for patients requiring repeated or difficult vascular access.
Market Challenges
Pricing pressure is a significant challenge, particularly for basic peripheral IV cannulas that have become highly commoditized. Manufacturers of premium products must demonstrate clinical and economic advantages to healthcare procurement organizations. Training requirements and supply-chain reliability also remain important concerns for high-volume hospital consumables.
By product type, vascular access cannulas held the largest market share in 2025 due to extensive use across emergency care, oncology, surgery, dialysis, ICUs, and general wards. Nasal cannulas are projected to grow at a 6.4% CAGR.
By material, plastic cannulas dominated in 2025 owing to flexibility, affordability, disposability, and patient comfort. The segment is estimated to account for 74.1% of the market in 2026. Silicone cannulas are projected to register a 6.8% CAGR.
By usage, disposable cannulas led the market in 2025, while reusable cannulas are projected to grow at a 2.9% CAGR. By age group, adults represented the largest segment, while the pediatric segment is expected to grow at a 4.8% CAGR.
By end-user, hospitals & ASCs dominated in 2025 and are projected to account for 64.9% of the market in 2026. Specialty clinics are forecast to register a 6.1% CAGR.
North America dominated with USD 1.02 billion in 2025, compared with USD 0.97 billion in 2024. The U.S. market is projected to reach USD 0.99 billion in 2026, representing approximately 38.9% of global revenues.
Asia Pacific is expected to become the second-largest regional market at approximately USD 0.74 billion in 2026. China, Japan, and India are projected to reach approximately USD 0.30 billion, USD 0.21 billion, and USD 0.10 billion, respectively.
Europe is projected to reach USD 0.62 billion in 2026 and record a 4.8% growth rate during the forecast period. Germany and the U.K. are estimated at USD 0.16 billion and USD 0.11 billion, respectively, in 2026. Latin America is estimated at approximately USD 0.07 billion in 2026, while the GCC market is projected at around USD 0.02 billion.
Competitive Landscape
Leading companies include BD, B. Braun SE, Terumo Medical Corporation, ICU Medical, Teleflex Incorporated, Vygon, Polymed, Romsons Group of Industries, Medtronic, and LivaNova. BD, Teleflex, B. Braun, and Medtronic held prominent positions in 2025 due to extensive portfolios, hospital relationships, safety technologies, and global distribution networks.
Key Industry Developments
In February 2026, Vygon acquired Stiletto and SlipStream technology from Avia Vascular to strengthen mid-duration peripheral cannulation. In April 2025, Vapotherm introduced its Unicorn single-prong nasal cannula. Other notable developments include Medtronic's VitalFlow ECMO system, B. Braun's Introcan Safety 2 Deep Access IV Catheter, and Teleflex's Arrow EZ-IO Intraosseous Access Procedure Tray.
Conclusion
The cannula market is expected to maintain steady expansion as hospitals increasingly require safe, reliable, and procedure-specific vascular and respiratory access products. The global market progresses from USD 2.41 billion in 2025 to USD 2.55 billion in 2026 and is projected to reach USD 3.93 billion by 2034, at a 5.5% CAGR. Rising surgical volumes, chronic disease treatment, critical care requirements, disposable device adoption, and safety-engineered cannulas will remain major growth contributors through 2034.
Segmentation By Product Type, Material Type, Usage, Age Group, End-user, and Region
By Product Type
By Material Type
By Usage
By Age Group
By End-user
By Region